Loading clinical trials...

Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience | Clinical Trials | Clareo Health

COMPLETEDNA

Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience

NCT06655935•Egyptian Biomedical Research Network

View on ClinicalTrials.gov

Summary

Transcatheter closure of secundum atrial septal defects is widely approved worldwide, yet it still has multiple risks like perforation and radiation exposure. In this study, we proposed a modified rapid method for closure of secundum atrial septal defects, to avoid material manipulation inside your heart and decrease complication rate.

Detailed Description

Delivery sheath can be advanced over multipurpose catheter instead of stiff wire

Eligibility

Age

3 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Any patient with ostium secundum ASD \& RV volume overload

Exclusion Criteria

•Any other type of atrial septal defects Any other associated congenital anomaly

Locations (1)

Tanta University

Tanta, Egypt

Key Dates

Start Date

June 1, 2022

Primary Completion Date

June 1, 2023

Completion Date

June 30, 2023

Last Updated

October 29, 2024

Enrollment

ACTUAL participants

Conditions

Atrial Septal Defect (ASD)

Interventions

Ordinary Transcatheter ASD closure

PROCEDURE

modified transcatheter ASD closure

PROCEDURE

FIH Study With CBSO

NCT01960491

Atrial Septal Defect (ASD)Patent Foramen Ovale (PFO)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions